S&P 500

5.307,01

-0,27%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Kitov Pharma Ltd (KTOV)
Kitov Pharma Ltd (KTOV) Notícias

KTOV

Kitov Pharma (KTOV)

Kitov Pharma Ltd

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:KTOV

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
20/06/2023	09:01	Edgar (US Regulatory)	Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)	NASDAQ:KTOV	Kitov Pharma Ltd
15/06/2023	17:01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:KTOV	Kitov Pharma Ltd
05/04/2023	18:22	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:KTOV	Kitov Pharma Ltd
23/03/2023	10:23	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:KTOV	Kitov Pharma Ltd
03/03/2023	09:58	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:KTOV	Kitov Pharma Ltd
23/03/2022	18:22	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:KTOV	Kitov Pharma Ltd
09/04/2021	17:35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KTOV	Kitov Pharma Ltd
16/03/2021	16:23	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:KTOV	Kitov Pharma Ltd
04/02/2021	18:30	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:KTOV	Kitov Pharma Ltd
23/11/2020	18:17	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:KTOV	Kitov Pharma Ltd
08/09/2020	08:45	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:KTOV	Kitov Pharma Ltd
20/07/2020	07:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:KTOV	Kitov Pharma Ltd
14/07/2020	17:04	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:KTOV	Kitov Pharma Ltd
30/06/2020	07:25	Edgar (US Regulatory)	Amended Report of Foreign Issuer (6-k/a)	NASDAQ:KTOV	Kitov Pharma Ltd
18/05/2020	18:25	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:KTOV	Kitov Pharma Ltd
11/03/2020	10:17	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	NASDAQ:KTOV	Kitov Pharma Ltd
27/12/2019	18:10	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1)	NASDAQ:KTOV	Kitov Pharma Ltd
11/10/2019	09:54	GlobeNewswire Inc.	Kitov Pharma Announces Amended Marketing and Distribution Agreement with Coeptis and Provides Update on the Upcoming Launch ...	NASDAQ:KTOV	Kitov Pharma Ltd
02/10/2019	09:20	GlobeNewswire Inc.	Kitov Pharma Appoints Eric K. Rowinsky, M.D., as Chairman of its Board	NASDAQ:KTOV	Kitov Pharma Ltd
09/09/2019	09:30	GlobeNewswire Inc.	Kitov Pharma Presents Newly Released Data for NT-219 in Reversing Pancreatic Cancer Drug Resistance	NASDAQ:KTOV	Kitov Pharma Ltd
03/09/2019	09:22	GlobeNewswire Inc.	Kitov Pharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference	NASDAQ:KTOV	Kitov Pharma Ltd
29/08/2019	09:30	GlobeNewswire Inc.	Kitov Pharma to Present New Data on NT-219 Targeting Cancer Drug Resistance at the AACR Pancreatic Cancer: Advances in Scienc...	NASDAQ:KTOV	Kitov Pharma Ltd
16/08/2019	09:24	GlobeNewswire Inc.	Kitov Pharma Announces Significant Progress in Closing of FameWave Acquisition Deal	NASDAQ:KTOV	Kitov Pharma Ltd
14/08/2019	09:20	GlobeNewswire Inc.	Administrative Enforcement Agreement Finalized between Kitov Pharma and the Israeli Securities Authority	NASDAQ:KTOV	Kitov Pharma Ltd
08/08/2019	09:20	GlobeNewswire Inc.	Kitov Pharma Reports First Half 2019 Financial Results and Provides Business Update	NASDAQ:KTOV	Kitov Pharma Ltd
12/07/2019	18:11	GlobeNewswire Inc.	Kitov Receives Nasdaq Notification Regarding Minimum Bid Requirements	NASDAQ:KTOV	Kitov Pharma Ltd
27/06/2019	08:30	GlobeNewswire Inc.	Kitov Successfully Completes IND-enabling Studies to advance NT219 for the Treatment of Patients with Recurrent or Metastatic...	NASDAQ:KTOV	Kitov Pharma Ltd
10/05/2019	10:20	GlobeNewswire Inc.	Kitov Receives Notice of Allowance for Additional U.S. Patent Covering its Commercial Product Consensi™	NASDAQ:KTOV	Kitov Pharma Ltd
09/05/2019	09:30	GlobeNewswire Inc.	Kitov to Present Clinical Development Plan for Oncology Candidate NT-219 at the 18th MIXiii-BIOMED Conference	NASDAQ:KTOV	Kitov Pharma Ltd
02/05/2019	17:45	GlobeNewswire Inc.	Kitov Announces Retirement of Founder and Executive Chairman Dr. Paul Waymack	NASDAQ:KTOV	Kitov Pharma Ltd